Background: The aim of the study was to evaluate the antibacterial effect of a drug releasing poly (3-hydroxybutyrate) (P(3HB)) implant coating in comparison to pure titanium on Aggregatibacter actinomycetemcomitans as a model periodontopathogen to prevent biofilm formation on implant surfaces. Methods: Titanium discs were coated with P(3HB) containing 5% (w) and 10% (w) of metronidazole, either with and without a P(3HB) topcoat. The biofilm formation was evaluated after 1, 4 and 9 days in a dynamic flow chamber system. Microbial adherence was quantified by determination of bacterial surface coverage. Results: The evaluated formulations of P(3HB)/metronidazole showed an antibacterial effect especially in the first 24 h. Prolonged incubation for 9 days showed reduced bacterial adhesion only on polymer coatings loaded with 10% (w) of metronidazole both with and without topcoat.
Background
Today, dental implant treatment is an important part of rehabilitation in up to date dentistry. Modern implant systems show survival rates of up to 95% [1] , [2] . Important for short and long term success is the prevention of bacterial adhesion to subgingival implant regions [3] . There, the microorganisms can form pathogenic biofilms that slowly spread about the implant surface causing severe inflammatory reactions. If untreated, these processes usually result in complete implant loss.
A multitude of medically relevant bacteria form biofilms in their sessile life stage [4] . In the oral cavity, these bacterial communities are characterized by their multi-species nature and a highly organized biofilm formation process [5] . The inhabiting cells are embedded in a protective microenvironment composed of secreted extracellular polymeric substances (EPS). These substances mediate tight adherence to the substratum surface also as promoting intercellular adhesion [6] . Furthermore, the EPS matrix functions as a barrier against antimicrobial agents, predation as well as the host's immune response. In that respect, a pharmaceutical or host's immunological intervention usually fails to provide biofilm clearance [7] . Since the first use of antibiotic-added bone cement in the 1970's [8] , strategies for local drug release have become valuable tools for treatment and prevention of medical complications [9] , [10] , [11] . These approaches can provide effective drug concentrations directly at the implant site and simultaneously avoid high systemic drug loads. In oral implantology, local drug release can be realized by an antimicrobial implant coating. In this respect, mechanical resistance, biocompatibility as well as a stable, continuous drug release are vital criteria for their success with regard to reduction of risk of the development of peri-implantitis [12] because biofilm is only occurred if the balance of bacteria is disturbed. This process is prevented by coating of implant surfaces.
Different studies have already investigated drug-releasing implant coatings and their influence on the development of peri-implantitis [13] , [14] , [15] . However , these coatings provide only short term protection against microbial colonization due to insufficient drug loading capacity or inadequate release kinetics. Based on these findings, the development of new, innovative coatings is necessary to improve long term success of dental implants. One promising approach could be to develop functionalisations with topcoats in order to influence release kinetics.
The aim of the present study was the evaluation of the antibacterial effect of drug releasing poly(3-hydroxybutyrate) (P(3HB)) coatings on A. actinomycetemcomitans biofilm formation in comparison to pure titanium in a flow chamber system under physiological-like flow conditions. A. actinomycetemcomitans was chosen because it is a periodontopathogen and metronidazole has an proven effect to this pathogen. Metronidazole was used for bactericial treatment of coatings due to its effectiveness against major periodontopathogens like Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola and of course Aggregatibacter actinomycetemcomitans. To the best of our knowledge, this was the first study analyzing the antibacterial effect of metronidazole containing dental implant coatings.
Methods

Preparation and characterization of the test specimens
All test specimens were manufactured of titanium Grade 4 (L.Klein SA, Biel, Schweiz), one of the most commonly used materials for dental implants. These were disc-shaped, with a diameter of 12 mm and a thickness of 1.5 mm (Figure 1 ). For improved adhesion of P(3HB) coatings, the titanium surfaces were plasma activated. Surface activation was carried out using a computerized low pressure plasma system (FEMTO, Diener electronic GmbH+Co.KG, Ebhausen, Germany) with the following settings: 0.3 mbar oxygen pressure, 2 min treatment time, 60% generator power output. For the coating process, polymer and metronidazole were individually solubilized in chloroform, respectively methanol and subsequently combined to give solutions of the following concentrations: a) 4 mg/mL P(3HB) and 5% metronidazole; b) 4 mg/mL P(3HB) and 10% metronidazole and c) no coating only pure titanium as control group. A control group with pure titanium was chosen because it was used typically in the oral cavity for dental implants. The polymer/antibiotic solutions were applied by spray coating to the titanium surfaces. Topcoats with a mean thickness of 47 μm of pure P(3HB) which reduced the release kinetics were applied in the same way. For each test specimen the total amount of incorporated metronidazole was determined gravimetrically with an ultra-microbalance (UMX 5, Mettler-Toledo GmbH, Giessen, Germany) at a resolution of ±0.1 μg (Table 1) . For this procedure the test discs were weighed after cleaning to determine the initial mass. The absolute mass of metronidazole was determined by back calculation. Each specimen disc was coated on one side for one time for 1200 h with P(3HB)/metronidazole and subsequently dried in a vacuum drying cabinet at a temperature of 40 °C for 48 h ( Table 2 ). 
High performance liquid chromatography (HPLC) to evaluate drug release kinetics
All test specimens were immersed in 1 mL elution medium (0.9 % NaCl) at 37 °C in a glass vial by shaking.
After each sampling the test specimen were immersed in fresh elution medium. In order to determine the metronidazole concentration, medium solution aliquots were injected into a Chromolith FastGradient column (RP18, 50 × 2 mm inner diameter; Merck, Darmstadt, Germany). The chromatographic conditions were: 50 °C column temperature, a phosphate buffer (c = 0.01 M, pH 4,55)/ methanol (90/10 v/v) eluent, isocratic, 0.3 mL/min flow rate, 317 nm detection UV, 0.1 to 20.0 mg/L calibrated measurement range, and a detection limit of ∼0.02 mg/L.
Bacterial strains and growth conditions
For the experiments the strain A. actinomycetemcomitans DSM 11123 was used. The bacterium was propagated under anaerobic conditions at 37 °C in brain heart infusion medium (BHI; Oxoid Ltd., England) supplemented with 5% (w) saccharose (Carl Roth, Germany).
Flow chamber experiments
Biofilm formation in the flow chambers was analyzed over a period of 9 days because the time until 10 days is critical for the first healing period of implants. Each flow chamber consisted of a base plate with a centered sampler holder, a silicone mat with a rhombic cutout forming the flow channel, a glass cover plate and a flow chamber housing. The sample holder accommodates the P(3HB) coated round shaped specimen. The inlet pipe of each chamber was connected to a bubble trap preventing air bubbles from entering the flow chambers. Prior to starting the experiment, the system was evacuated twice using a water jet-pump and filled with anaerobic gas mixture (80% N 2 , 10% H 2 , 10% CO 2 ). A gas filled balloon was connected to the device to create an overpressure that prevents oxygen from entering the bioreactor. A. actinomycetemcomitans was precultured for 5 days and used for inoculation of 2 L of saccharose supplemented BHI medium. The starting optical density at 600 nm (OD 600 ) was adjusted to 0.1 and the suspension was pumped (Ismatec IPC16; IDEX Health&Science GmbH, Germany) at a constant flow-rate of 100 μL/min over the samples. The outflow was collected in a waste container to inhibit accumulation of metronidazole in the culture medium. After 1 day, 4 days and 9 days a set flow chambers were disconnected from the system and microbial adherence was analyzed by scanning electron microscopy (SEM). Each set consisted of a pure polymer coated specimen as control, and the drug-eluting polymer coating.
SEM analysis and quantification of microbial surface coverage
The samples were dehydrated in an ascending ethanol row (25%, 50%, 75%, 90%, 100%), critical point dried (Balzers CPD30; Balzers Union, Liechtenstein) and gold coated (Polaron High Resolution Sputter Coater E 5400, Polaron Equipment Ltd., England). The biofilm formation on the individual samples was analyzed by SEM at 600× magnification. An investigation of life/death distribution was not possible because the colorants were absorbed and it is assumed that the use of an antibiotic leads to death of all bacterias. Microbial surface coverage was determined using the software package ImageJ at five different locations per sample: center, left, right, up, down. A analyse of number of colony forming units was not conducted because the objective of the present study was to evaluate if the coating works and if there were no bacterial adhesion.
Statistical analysis
The maximum and minimum value of surface coverage for each time point were eliminated from the data sets for statistical analysis. SPSS for Windows, version 23.0 (IBM, Ehringen, Germany) was used for statistical assessment. The surface coverage ratios between the samples were compared using 2-tailed Student's t-test for unpaired samples. Prior to the Student's t-test, both the Shapiro-Wilks test for the assessment of normality and the Levene test for equality of variances were conducted. The level of significance was set to 0.05, respectively.
Results
Release kinetics from P(3HB) coatings
All coatings showed the release of metronidazole of a period of at least 1100 h. In the beginning of the experiment an initial burst release was common to all coatings. In the later phase (>100 h) metronidazole release slowed down and remained at a relatively constant level up to the end of the experiment. However, drug release rates differed substantially between the different coating types (Figure 2 ). Highest release rates were observed for coatings without topcoat functionalization. About 50% of total incorporated metronidazole was set free from P(3HB)/metronidazole (90/10% w/w) coatings after 50 h and from P(3HB)/metronidazole (95/5% w/w) after 400 h of exposure. The metronidazole release from topcoat functionalized surfaces was substantially slower -30% of incorporated metronidazole were eluted from the coatings after 200 h for P(3HB)/metronidazole/topcoat (90/10% w/w) and 400h for P(3HB)/metronidazole/topcoat (90/5% w/w). 
Evaluation of the antibacterial e昀fect on the di昀ferent coating types
Attached bacteria or bacterial agglomerates were visible in the SEM micrographs as bright entities against a darker background. All drug loaded surfaces showed reduced microbial adhesion at least within the first 24 h. In Figure 3 and Figure 4 SEM micrographs of the control surface and P(3HB)/metronidazole (90/10% w/w) are exemplarily shown. On the metronidazole containing surface, substantially less, mostly isolated single cells were attached to the surface (Figure 3 ). By contrast, on the control surface cells mostly resided as clusters (≥2 cells) (Figure 4 ). On both surfaces most cells were structurally intact, without evident signs of cell damage. 
Antibacterial e昀fect: P(3HB)/metronidazole (95/5% w/w) without topcoat
Drug loaded surfaces showed significant reduction in microbial adherence from day 1 (p < 0.001) until day 4 (p = 0.007) compared to the control surfaces ( Figure 5 and Figure 6 ). However, after nine days no clear differences between the amounts of biofilm formation on surfaces with P(3HB)/metronidazole and the titanium specimens were detected ( Figure 7 ). The microbial surface coverage increased from 1.54% at day one to 17.93% after nine days on the drug-loaded discs and from 9.45% to 21.99% on the titanium control discs. Percentage of bacterial coverage on specimen surface after 4 days of cultivation in a flow chamber system; 5%Me = 5% metronidazole coating, 5%Me_TC = 5% metronidazole coating with topcoat, 10%Me = 10% metronidazole coating, 10%Me_TC = 10% metronidazole coating with topcoat, control = titanium surface.
Figure 7:
Box and Whisker Plot demonstrating the amount of biofilm after nine day. The boxes display the medians and the upper and lower quartiles; the whiskers represent the minimum and maximum values. Percentage of bacterial coverage on specimen surface after 4 days of cultivation in a flow chamber system; 5%Me = 5% metronidazole coating, 5%Me_TC = 5% metronidazole coating with topcoat, 10%Me = 10% metronidazole coating, 10%Me_TC = 10% metronidazole coating with topcoat, control = titanium surface.
Antibacterial e昀fect: P(3HB)/metronidazole (95/5% w/w) with topcoat
The surface coverage on metonidazole loaded surfaces with topcoat was significantly reduced after 24 h (p = 0.039) compared to the titanium control ( Figure 5 ). For the following time points no statistically relevant differences were observed. The total surface coverage increased from 4.62% after one day to 25.39% after nine days on metronidazole-loaded coating ( Figure 5 and Figure 7 ). On pure titanium specimens the amount of biofilm ranged from 18.69% after the first 24 h to 31.64% after the whole period of nine days.
Antibacterial e昀fect: P(3HB)/metronidazole (90/10% w/w) without topcoat
The drug loaded surfaces showed significantly decreased amounts of bacteria on day 1 (p < 0.001) and day 9 (p = 0.016) ( Figure 5 and Figure 7) . Surprisingly, this effect was not observed on day 4 ( Figure 6 ). The biofilm amounts of the whole time period ranged from 2.12% to 24.29% for the P(3HB) drug coated specimens and from 12.96% to 34.59% for the titanium surfaces.
Antibacterial e昀fect: P(3HB)/metronidazole (90/10% w/w) with topcoat
A significant decrease of biofilm formation on P(3HB)/metronidazole (90/10% w/w) coatings with topcoat was observed for all tested timepoints; day 1 (p = 0.006), day 4 (p = 0.001) and day 9 (p = 0.032). The total biofilm surface coverage ranged from 5.21% after the first 24 h to 16.65% after nine days on the metronidazole coated specimens and from 15.75% to 30.74% on the titanium control surfaces ( Figure 5 and Figure 7 ).
Discussion
Dental implants treatment can be complicated by bacterial infections [16] , [17] that reduce short and long term success. In front of this problem numerous studies have focused on the development of drug releasing implant coatings for the prevention of bacterial adhesion [13] , [16] , [18] , [19] and subsequent biofiom formation.
In the present study we evaluated different types of metronidazole-loaded P(3HB) coatings for their in vitro antimicrobial activity against A. actinomycetemcomitans under physiological-like flow conditions. The P(3HB) polymer coatings have already been shown to be effective drug carrier system for medical devices in several other studies [20] , [21] , [22] , [23] , [24] . The bacterial attachment to the pure titanium differed significantly to the drug-loaded surfaces. In the most cases the bacterial coverage on the metronidazole-loaded P(3HB) surfaces was significantly lower in comparison to the control specimens consisting of pure titanium. The experimental setting did not allow for direct assessment of the bacterial viability state. However, on the P(3HB)/metronidazole surface ( Figure 3 ) bacteria appeared mostly as isolated, single cells not showing any signs of cell division. By contrast, on the control surfaces cell proliferation was observable, i.e. formation of small cell clusters due to cell division ( Figure 4 ). This indirectly confirmed the disinfection effect through metronidazole release form the drug containing coating.
As seen in Figure 2 , all coatings showed an initial burst release setting off high doses of metronidazole from the surfaces. However, the release from non-functionalized surfaces, i.e. P(3HB)/drug coatings was more strongly pronounced. It can be assumed that metronidazole crystals, located on the polymer matrix surface (Figure 8 and Figure 9 ), accounted for these findings. Exposed active substance particles can quickly be solubilized by the aqueous phase and promote setting off high drug doses during the initial burst phase. By applying a topcoat layer, this process was slowed down, as the metronidazole crystals were covered and not directly exposed to the liquid phase ( Figure 10 and Figure 11 ). Accordingly, the topcoat modified surfaces showed a more enduring antibiotic release, however at much lower drug release rates compared to the non-functionalized coatings. It was shown that the higher concentration of metronidazole in the polymer coating -especially with a release-delaying topcoat modification -had a longer antibacterial effect so that bacterial surface coverage differed significantly to the pure titanium discs especially in the second and last time period. For the lower drug concentration the antibacterial property was observed only after the first and the second fraction of time. Here, the combination of low drug concentrations and topcoat gave inferior results probably, due to an extensively slowed down drug release.
Obviously, an effective antibiotic concentration on the surfaces containing lower drug concentrations with topcoat was not maintained after prolonged incubation, so that A. actinomycetemcomitans surface colonization was not abolished but rather proceeded.
The polymer coatings with 10% incorporated metronidazole and a release-delaying topcoat modification -showed a longer antibacterial effect so that surface coverage differed significantly to the pure titanium discs especially in the second and last time period. For the lower drug concentration the antibacterial property was observed only after the first and the second fraction of time. Here, the combination of low drug concentrations and topcoat gave inferior results probably, due to the extensively slowed down drug release (Figure 2) . Short-term protection from bacterial adhesion with a metronidazole containing coating was already described in different studies [25] , [26] , however in these cases different coating formulations were used so that these results can not be directly applied to our study. For example Lui et al. [18] investigated a metronidazole impregnated calcium phosphate coating on titanium surfaces. The authors showed that the metronidazole coating provided only short-term protection from microbial colonization. There, after two and four days the antimicrobial properties of the coating were lost. Analogously to our results, Norowski et al. [13] confirmed a short term antibacterial effect of their implant coating. They evaluated a chitosan coating loaded with tetracycline and chlorhexidine and demonstrated that it can reduce the risk of infections for a short period of time. The study showed that the coating was depleted for chlorhexidine after two and tetracycline after seven days , respectively. Xing et al. [27] analyzed the antibacterial effect of doxycycline-coated dental abutments and observed reduced biofilm formation on the functionalized surfaces. Similar to the the results of our study, a high drug-load was essential for keeping up antibacterial activity over a prolonged period of time.
In our study, we demonstrated that the tested formulation of P(3HB) coatings with incorporated metronidazole can improve the prevention of bacterial adhesion temporary, especially in combination with high drug concentrations and a release-delaying topcoat. Consequently, more investigations are necessary to reach a longterm antimicrobial effect on implant surfaces, so that the risk of periimplantitis can be reduced.
